Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Post by blabbermouthon Apr 27, 2007 7:48am
128 Views
Post# 12684596

Insiders buying MBX-last 10 trades all buys

Insiders buying MBX-last 10 trades all buyshttps://www.canadianinsider.com/coReport/allTransactions.php?ticker=MBX Filing Date Transaction Date Insider Name Nature of transaction Securities # or value acquired or disposed of Unit Price Mar 09/07 Feb 28/07 Blecher, Peter Martin 10 - Acquisition in the public market Common Shares 2,500 $0.644 Mar 09/07 Feb 28/07 Blecher, Peter Martin 10 - Acquisition in the public market Common Shares 12,500 $0.614 Mar 09/07 Dec 15/05 Blecher, Peter Martin 00 - Opening Balance-Initial SEDI Report Common Shares Mar 08/07 Dec 15/05 Blecher, Peter Martin 00 - Opening Balance-Initial SEDI Report Options Mar 05/07 Feb 06/07 Embro-Pantalony, Vaughn 50 - Grant of options Options 125,000 Mar 05/07 Feb 06/07 Embro-Pantalony, Vaughn 00 - Opening Balance-Initial SEDI Report Options Feb 27/07 Feb 22/07 Long, James Albert 10 - Acquisition in the public market Common Shares 10,000 $0.600 Feb 26/07 Feb 23/07 Casselli, Philip Jonathan 10 - Acquisition in the public market Common Shares 8,000 $0.600 Feb 22/07 Feb 22/07 Hughes, Kenneth 10 - Acquisition in the public market Common Shares 3,500 $0.600 Feb 22/07 Feb 22/07 Gastle, William John 10 - Acquisition in the public market Common Shares 16,000 $0.600
Bullboard Posts